2025
Multimodal MRI accurately identifies amyloid status in unbalanced cohorts in Alzheimer’s disease continuum
Dolci G, Ellis C, Cruciani F, Brusini L, Abrol A, Galazzo I, Menegaz G, Calhoun V, Initiative F. Multimodal MRI accurately identifies amyloid status in unbalanced cohorts in Alzheimer’s disease continuum. Network Neuroscience 2025, 9: 259-279. PMID: 40161995, PMCID: PMC11949592, DOI: 10.1162/netn_a_00423.Peer-Reviewed Original ResearchNeuropathological hallmarks of Alzheimer's diseaseHallmarks of Alzheimer's diseaseHyperphosphorylated tau proteinAmyloid-bTau proteinNeurofibrillary tanglesNeuropathological hallmarksAmyloid accumulationAlzheimer's diseaseAb accumulationDepositional signatureIdentification of individualsAmyloid statusAccumulationAmyloidShed lightTanglesAlzheimer's disease continuumProtein
2017
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
Xia C, Makaretz S, Caso C, McGinnis S, Gomperts S, Sepulcre J, Gomez-Isla T, Hyman B, Schultz A, Vasdev N, Johnson K, Dickerson B. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease. JAMA Neurology 2017, 74: 427-436. PMID: 28241163, PMCID: PMC5470368, DOI: 10.1001/jamaneurol.2016.5755.Peer-Reviewed Original ResearchConceptsStructural magnetic resonance imagingAlzheimer's diseaseCortical atrophyHyperphosphorylated tau proteinClinical phenotypeTau in vivoAssociation in vivoAtypical Alzheimer's diseaseMagnetic resonance imagingTau proteinMeasure amyloid burdenPositron emission tomographicNeurofibrillary tanglesMeasure cortical thicknessOutpatient referral centerDisease-modifying therapeuticsTau PET imagingCarbon 11-labeled Pittsburgh Compound BCognitive functionIn vivo evidenceCortical regionsResonance imagingPostmortem studiesCortical thicknessNeurodegenerative diseases
2012
Striatal-Enriched Protein Tyrosine Phosphatase in Alzheimer’s Disease
Xu J, Kurup P, Nairn AC, Lombroso PJ. Striatal-Enriched Protein Tyrosine Phosphatase in Alzheimer’s Disease. Advances In Pharmacology 2012, 64: 303-325. PMID: 22840751, PMCID: PMC3740556, DOI: 10.1016/b978-0-12-394816-8.00009-x.Peer-Reviewed Original ResearchConceptsAlzheimer's diseaseNeurofibrillary tanglesStriatal-enriched protein tyrosine phosphataseAmyloid plaquesTreatment of ADHyperphosphorylated tau proteinSubstantial economic burdenProgressive diseasePotential clinical applicationsClinical symptomsBeta amyloidGlutamate receptorsEconomic burdenTau proteinCortical accumulationCognitive functionMemory lossBeneficial effectsDiseaseNeuronal membranesCommon formMultiple intracellularMillions of peopleClinical applicationImportant target
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply